The global pharmaceutical contract development and manufacturing market are expected to record an average annual growth rate of +7%, from $ +95 billion in 2019 to $ +150 billion by 2024. The growth in this market is driven by increased demand for generics, increased investment in pharmaceutical R & D, and investment in advanced manufacturing technologies in CDMO.

The pharmaceutical manufacturing sector is expected to account for the largest share of the pharmaceutical contract development and manufacturing market in 2019.

Pharmaceutical manufacturing services are expected to make the biggest profits on the market in 2019, with most of these segments increasing the need to reduce manufacturing costs, high-quality bulk manufacturing requirements, increasing demand for generic drugs, high operating costs and lack of in-house manufacturing capabilities.

Request the Sample Report Here: https://www.marketresearchinc.com/request-sample.php?id=10045

Key Market Segments:

Key Market Players:

Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Lonza Group Ltd (Switzerland), Recipharm AB (Sweden), Vetter Pharma International GMBH (Germany), FAMAR Health Care Services (Greece), AbbVie Inc. (US), Aenova Group (Germany), Consort Medical plc (UK), Almac Group (UK), Siegfried Holding AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), and Evonik Industries AG (Germany).

By Service
  • Pharmaceutical Manufacturing Services
    • Pharmaceutical API Manufacturing
    • Pharmaceutical FDF Manufacturing
      • Parenteral/Injectable
      • Tablet
      • Capsule
      • Oral Liquid
      • Other Formulations
  • Biologics Manufacturing Services
    • Biologics API Manufacturing
    • Biologics FDF Manufacturing
  • Drug Development Services
By End-User
  • Big Pharma
  • Small & Mid-size Pharma
  • Generic Pharmaceutical Companies
  • Other End Users
By Region
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
Speak to our analyst for a discussion on the above findings, and ask for a discount on the report: https://www.marketresearchinc.com/ask-for-discount.php?id=10045 Parenteral/injectable manufacturing services are expected to grow at high CAGR The pharmaceutical FDF manufacturing services market includes parenteral / injectables, tablets, capsules, oral liquid, and other formulation manufacturing services, depending on the type. Parenteral/injectable manufacturing services are expected to grow at the highest CAGR during the forecast period due to factors such as the need for high levels of expertise, an increased number of sterile preparations, and increased drug development activity. The large pharmaceutical end-user segment is expected to account for the largest share of the pharmaceutical contract development and manufacturing market in 2019 Large pharmaceutical end-user segments accounted for the largest market share in the market in 2019. This is due to the emergence of new forms of medicine and treatment, price pressures, pipeline problems and opportunities for growth in emerging markets. Asia-Pacific is expected to grow at the highest rate in the pharmaceutical contract development and manufacturing market in 2019 The Asia Pacific market is expected to grow at the highest CAGR over the forecast period. This is due to the growing growth in the manufacturing sector, government-controlled favors, the emphasis on non-patent drugs, and the highly skilled workforce outsourcing pharmaceutical contract development and manufacturing to the Asia Pacific. Report Customization and Benefits: This report can be customized to meet the desired requirements. Please connect with our analyst, who will ensure that you get a report that suits your needs. Table of Content: Chapter One Pharma Contract Manufacturing Organizations Overview Chapter Two Industry Chain Analysis Chapter Three Market Dynamics of PHARMA CONTRACT MANUFACTURING ORGANIZATIONS Industry Chapter Four Europe Market of PHARMA CONTRACT MANUFACTURING ORGANIZATIONS (2014-2019) Chapter Five Europe Market Forecast (2019-2024) Chapter Six Europe Raw Material Supply Analysis Chapter Seven Europe PHARMA CONTRACT MANUFACTURING ORGANIZATIONS Consumer Analysis Chapter Eight Analysis of Europe Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.) Chapter Nine Research Conclusions of Europe PHARMA CONTRACT MANUFACTURING ORGANIZATIONS Industry About Us: Market Research Inc is farsighted in its view and covers the massive ground in global research. Local or global, we keep a close check on both markets. Trends and concurrent assessments sometimes overlap and influence the other.  When we say market intelligence, we mean a deep and well-informed insight into your products, market, marketing, competitors, and customers. Market research companies are leading the way in nurturing global thought leadership. We help your product/service become the best they can with our informed approach. Contact Us: Author Kevin US Address: 51 Yerba Buena Lane, Ground Suite, Inner Sunset San Francisco, CA 94103, USA Call Us: +1 (628) 225 1818 Email: sales@marketresearchinc.com